Tuesday 15th October – ½ day virtual meeting
13.00 – 16.20 (BST) – Via Zoom
Member Fee £350 (Join Now) / Non-Member Fee £450
Additional discounted rates for NHS / Not-for-profit organisations (See booking form)
Pyrogen Detection has been an area for the Pharmaceutical Microbiologist that has observed a wind of change in recent years. There have been many regulatory changes and proposed updated in recent years, spanning across bacterial endotoxin testing and into pyrogen detection.
Understanding the various regulatory requirements is important to provide a strategy to provide assurance of the quality of the products that are being manufactured. It may be a combination of risk assessment, one-off studies during development and routine end-product testing.
This virtual meeting will span across pyrogen detection, from the use of Monocyte Activation Testing to the adoption of recombinant reagents for bacterial endotoxin testing. Topics will include case studies on endotoxin failures, validation of new methods and an insight into recent regulatory changes across the globe.
The meeting will start by setting the scene by introducing the various different types of pyrogen that may require detection in pharmaceutical production processes.
This virtual meeting is targeted to those working with contamination control strategies to obtain an overarching understanding of the different aspects to consider, it will be of interested to microbiologist, quality control and quality assurance professionals responsible for risk-based decision making, and those considering adapting their current pyrogen control approaches, whether that be switching bacterial endotoxin testing to a recombinant alternative or responding to European regulatory updates on pyrogen testing.
Please click here to view the full agenda outline and fees etc
